http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020118843-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf03088441cbbd44c36712aebc67692f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate | 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f1dcba025be5379ff5ce5e99cde3836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d8ac2242f07eaa1248cfff89e5122a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0077fafef88bd51bb9424933104c33fb |
| publicationDate | 2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020118843-A1 |
| titleOfInvention | Glp-1 mutant, preparation method and application thereof |
| abstract | Disclosed is a GLP-1 mutant. Also disclosed is a nucleotide sequence encoding the GLP-1 mutant, a recombinant vector and a recombinant bacteria containing the nucleotide sequence, a preparation method and a use of the GLP-1 mutant. The present invention also provides a drug for treating diabetes or weight control. The drug containing the GLP-1 mutant can effectively reduce blood sugar concentration or reduce weight and fat, can be used for treating type II diabetes or obesity, and has good clinical application prospects. |
| priorityDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.